L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea · Delayed Price · Currency is KRW 51,600
+1,750 (3.51%)
Oct 10, 2025, 3:30 PM KST
L&C BIO Co.,LTD Market Cap
L&C BIO Co.,LTD has a market cap or net worth of 1.27 trillion as of October 10, 2025. Its market cap has increased by 227.10% in one year.
Market Cap
1.27T
Enterprise Value
1.33T
Revenue
75.98B
Ranking
n/a
PE Ratio
10.35
Stock Price
51,600.00
Market Cap Chart
Since November 1, 2018, L&C BIO Co.,LTD's market cap has increased from 194.97B to 1.27T, an increase of 551.57%. That is a compound annual growth rate of 30.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 1,270.33B | 132.36% |
| Dec 30, 2024 | 546.71B | -16.90% |
| Dec 28, 2023 | 657.86B | 25.54% |
| Dec 29, 2022 | 524.02B | -36.89% |
| Dec 30, 2021 | 830.27B | 10.00% |
| Dec 30, 2020 | 754.76B | 300.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.17T |
| Celltrion | 38.24T |
| ALTEOGEN | 24.66T |
| Yuhan | 9,028.52B |
| SK Biopharmaceuticals | 8,136.75B |
| Peptron | 6,866.96B |
| PharmaResearch | 5,631.19B |
| LigaChem Biosciences | 5,483.63B |